Berlinger and BD push innovation in Blood Collection with the new MDR

Berlinger and BD push innovation in Blood Collection with the new MDR

iNADO Webinar

Release date
23/09/2021

Berlinger and BD push innovation in Blood Collection with the new MDR

Join Patricia Benninger, Clinical Specialists at Becton Dickinson, for her virtual training session of the new needle technology and get to know the whole range of benefits for the anti-doping community. Learn from Oliver Gehrig, Head of Sales & Marketing Anti-Doping Products at Berlinger, about the effects of the European MDR on the EU and the advantages for international customers. The webinar is organized by the Institute of National Anti-Doping Organisations (iNADO).

We at Berlinger have taken the new European Medical Device Regulation (MDR) 2017/745 as an opportunity to update to the latest generation of blood collection needles from Beckton Dickinson.

What you will learn:

The MDR has a huge impact on our customers, in Europe especially, as each accessory package requires a separate and extensive validation. As part of this major project, we at Berlinger updated the blood collection needles in all human blood accessories to ensure continuity and innovation in times that are fragile and unpredictable due to the pandemic. These needles guarantee less trauma and pain during the blood collection process for the athletes, the highest blood quality for analysis and a high level of security in order to avoid needle stitches for the blood collection officers.

Meet the Speakers:  

  • Dr. Oliver Gehrig, Head of Sales & Marketing Anti-Doping Products,  Berlinger
  • Patricia Benninger, Clinical Specialists, BD Life Sciences – Integrated Diagnostic Solutions, Becton Dickinson

Date & Time:

  • Tuesday, October 19, 2021 | 2:00 - 3:00 PM CEST

How to register:

We invite you to join this training session (hosted by iNADO) and encourage you to actively participate in the Q&A. ► Link to the registration